Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 167

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

100	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	12/19/2013 8:48:26 AM
99	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	12/18/2013 2:22:14 PM
98	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	12/18/2013 1:52:45 PM
97	Nuvilex Announces Cloning of Cells for Phase 3	stocklegend	12/18/2013 1:28:59 PM
96	$NVLX Nuvilex Completes Acquisition of	stocklegend	12/18/2013 1:16:18 PM
95	$NVLX Nuvilex Accelerates Development of	stocklegend	12/18/2013 12:44:59 PM
94	Nuvilex's Acquisition of Diabetes Rights Should	stocklegend	12/18/2013 12:26:46 PM
93	$NVLX Nuvilex Ahead of the Curve on	stocklegend	12/18/2013 12:01:07 PM
92	$NVLX Investors Confidently Back Nuvilex's	stocklegend	12/18/2013 11:48:52 AM
91	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	12/18/2013 11:37:29 AM
90	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	12/18/2013 11:27:08 AM
89	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	12/18/2013 11:07:55 AM
88	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	12/18/2013 11:02:01 AM
87	$NVLX Nuvilex Begins Making Moves at its	stocklegend	12/18/2013 10:57:29 AM
86	NVLX NEWS!!!	stocklegend	12/18/2013 10:20:59 AM
85	NVLX NEWS!!!	stocklegend	12/18/2013 10:01:19 AM
84	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	12/17/2013 3:42:05 PM
83	$NVLX Nuvilex COO Talks About Companys	stocklegend	12/17/2013 2:48:48 PM
82	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	12/17/2013 2:32:44 PM
81	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	12/17/2013 1:56:56 PM
80	Nuvilex Announces Cloning of Cells for Phase 3	stocklegend	12/17/2013 1:25:35 PM
79	$NVLX Nuvilex Accelerates Development of	stocklegend	12/17/2013 12:42:26 PM
78	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	12/17/2013 12:14:18 PM
77	Nuvilex Ahead of the Curve on Cannabidiol as FDA	stocklegend	12/17/2013 11:55:12 AM
76	$NVLX Investors Confidently Back Nuvilex's	stocklegend	12/17/2013 11:29:29 AM
75	Diabetes Treatment Drives Big Increase in	stocklegend	12/17/2013 10:52:08 AM
74	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	12/17/2013 10:26:00 AM
73	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	12/17/2013 10:04:07 AM
72	Nuvilex Appoints Dr. Mark Rabe, a Leading Figure	stocklegend	12/17/2013 9:52:29 AM
71	$NVLX Nuvilex Begins Making Moves at its	stocklegend	12/17/2013 9:42:10 AM
70	Nuvilex's Medical Marijuana Subsidiary Appoints	stocklegend	12/17/2013 8:56:15 AM
69	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	12/16/2013 3:17:47 PM
68	$NVLX Nuvilex Completes Acquisition of	stocklegend	12/16/2013 2:11:32 PM
67	$NVLX Nuvilex Accelerates Development of	stocklegend	12/16/2013 1:08:12 PM
66	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	12/16/2013 12:27:27 PM
65	Nuvilex Ahead of the Curve on Cannabidiol as FDA	stocklegend	12/16/2013 12:02:24 PM
64	Investors Confidently Back Nuvilex's Acquisition	stocklegend	12/16/2013 11:27:12 AM
63	Diabetes Treatment Drives Big Increase in	stocklegend	12/16/2013 10:47:51 AM
62	After Pancreatic Cancer, Eli Lilly and Nuvilex	stocklegend	12/16/2013 10:19:50 AM
61	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	12/16/2013 10:08:07 AM
60	Huge News Out On NVLX!!!!	stocklegend	12/16/2013 9:32:19 AM
59	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	12/16/2013 9:30:49 AM
58	Nuvilex Begins Making Moves at its Medical	stocklegend	12/16/2013 9:14:21 AM
57	Nuvilex's Medical Marijuana Subsidiary Appoints	stocklegend	12/16/2013 8:46:18 AM
56	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	12/13/2013 1:34:52 PM
55	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	12/13/2013 1:26:37 PM
54	NVLX Is The Mover Of The Week!!! Check This Out!	stocklegend	12/13/2013 12:51:10 PM
53	$NVLX- Check out this Video Breaking Science :	Picky Trader	12/13/2013 12:40:35 PM
52	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	12/13/2013 12:16:24 PM
51	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	12/13/2013 11:31:50 AM

Newer

Older

Recent Articles

• Anoto Group’s Interim Report Highlights Challenges and Progress
• Simplify's Projected Capital Gains Distribution for 2024
• Banco Macro Reports Impressive Growth in Q3 Performance
• Primis Financial Corp Faces Nasdaq Compliance Challenges
• Exploring the Growth of Patient Engagement Technology Market
• Data Monetization Market Expansion Driven by AI Innovations
• 20+ Companies Innovating in Myotonic Dystrophy Treatments
• HealthArc Enhances Remote Care Through athenahealth Partnership
• Compact Microfluidic Devices Drive Healthcare Innovations
• Jura Energy Corporation Reports Interim Financial Results
• Kenneth H. Traub Takes Charge as Executive Chairman at Comtech
• PJT Partners Inc. to Share Insights at Financial Services Event
• Advanced Wound Care Market Growth Fueled by AI Innovations
• Carbon Fiber Market Projected for Significant Growth Ahead
• Electric Commercial Vehicle Market Poised for Remarkable Growth
• Xcel Brands Addresses Nasdaq Compliance Issue Promptly
• Celularity Inc. Faces Nasdaq Compliance Challenges and Plan
• Exciting Developments for Helium Evolution in Resource Exploration
• American Rebel Holdings Plans to Regain Compliance with NASDAQ
• Exco Technologies Limited's Year-End Results Show Financial Resilience
• NANO Nuclear Energy Sees Major Growth with $60 Million Raise
• Primech Holdings Gains Time to Meet NASDAQ Bid Price Standards
• Wearable Devices Completes $1.85 Million Offering to Fuel Growth
• FrankSpeech Broadcast Network's Q3 Growth and Innovations Journey
• Gilead Sciences Celebrates Pivotal HIV Prevention Breakthrough
• Thunderbird Entertainment Group to Hold Annual Meeting 2024
• Franklin Resources Faces Legal Scrutiny: Key Insights for Investors
• Transforming Fleet Management: The ELD Market's Future Growth
• Industrial Machine Vision Market Set for Remarkable Growth
• OneStream Completes Successful Secondary Offering of Stock
• Transforming Healthcare: The Expanding Biomaterials Market
• Launch Two Acquisition Corp. Customizes Trading Options Ahead
• Join C&S Group Enterprises LLC's Upcoming Conference Call
• Hello There Collective Launches Innovative Influencer Platform
• Ostin Technology Group Shares Key Highlights from Recent Meeting
• Imperial Oil Set to Present Financial Outlook for 2025
• Nyxoah SA Reports New Shares and Voting Rights Overview
• Revolutionizing Space Communication with CubeSatGPT™ Technology
• Chemours Secures $600 Million in Senior Unsecured Notes
• Franklin Street Properties Expands Board with New Appointment
• Legal Action Open Against Dentsply Sirona Inc. Investors
• Horizon Copper Updates Investors on Project Developments
• Charles & Colvard, Ltd. Addresses Nasdaq Non-Compliance Notice
• Newtopia's Third Quarter Results Showcase Resilient Growth
• 24X National Exchange: A New Era of U.S. Trading Hours
• Union Drivers Stand Strong Against Amazon's Union Buster Tactics
• American Tire Distributors Moves Forward with Strategic Asset Deal
• Leeward Renewable Energy's Q3 2024 Financial Results Update
• Union Pacific Corporation Announces Consistent Dividend Commitment
• Pinnacle Bancshares Announces $0.27 Quarterly Dividend for Shareholders